Canada: Canada's Cannabis Opportunity In The Era Of Trump

Although the United States government's attitudes toward cannabis have eased in recent years, the election of President Donald Trump has generated renewed uncertainty surrounding the future of the U.S. cannabis market. Canada, conversely, will very likely soon be one of the first industrialized countries with fully legalized recreational and medical cannabis, and investment in the Canadian cannabis market has been unprecedented. Unburdened by the U.S.'s significant political and legal uncertainty, Canada has an opportunity to expedite its already rapid industry development to position itself as a global leader in the market for legal recreational and medical cannabis products.

The United States cannabis market is beset with uncertainty

The United States has historically approached cannabis conservatively. Cannabis is currently illegal federally; it is classified as a Schedule 1 Substance under the Controlled Substances Act of 1970,1 the schedule reserved for drugs said to be highly addictive and without medical value. However, under President Obama, the Department of Justice issued a memorandum in 2013 at the direction of United States Deputy Attorney General James Cole (the "Cole Memorandum") declaring that the federal government would take a state-centric, non-interventionist approach to the majority of local cannabis law enforcement issues if a given state legalized cannabis for recreational or medical purposes and implemented a "strong and effective regulatory and enforcement system" for its use and distribution.2 This federal policy was reinforced by the passage of a 2015 federal budget bill (passed in 2014) that prohibits the use of federal funds to interfere in the implementation of state cannabis laws. This bill targets Department of Justice funding, which encompasses the Drug Enforcement Agency. This bill shows the development of bi-partisan support in the U.S. Congress for legalizing the use of cannabis.

The Cole Memorandum and related policy changes have created a grey area. The U.S. federal government continues to view cannabis as unambiguously criminal and has not retracted its right to enforce federal law where it deems it appropriate, yet there has not to date been a court decision clarifying the circumstances under which the federal government can control state markets; the Supreme Court declined to hear a challenge to Colorado's cannabis laws as recently as March 2016. In fact, there has been significant state-level legalization momentum. There are currently 28 states which allow access to some form of cannabis, 8 which allow or are proposing to allow access recreationally,3 and the District of Columbia has allowed for limited recreational use without provision for commercial sale. Additional states have tabled similar legislation for 2017. Unsurprisingly, the U.S. market for legal cannabis has grown in conjunction with legalization; it is expected to be worth $7.1 billion in 2017 according to a 2016 report by New Frontier and ArcView market research.4

Notwithstanding a growing zeitgeist in favour of legalization, the development of state-level legalization legislation remains subject to continued federal support for the "hands off" approach advocated in the Cole Report. However, continued support remains uncertain. President Trump did not campaign on an anti-cannabis strategy, and an administration focused on small government seems unlikely to abandon a state centric approach and potentially lucrative revenue stream, particularly when the share of Americans in favour of legalization continues to increase; as of 2016 57% of Americans favoured legalization, up from only 32% just a decade ago.5 However, key members of Trump's administration have engaged in strong anti-cannabis rhetoric. Senator Jeff Sessions, President Trump's Attorney General, is a longstanding and vocal cannabis legalization opponent. Vice President Mike Pence, spoke out against a 2013 bill to reduce severe penalties for simple possession while serving as governor of Indiana, a strict anti-cannabis state. Neil Gorusch, President Trump's Supreme Court pick, does not have a clear position on the issue, however his hard-line stance on the criminal and textualist approach to legal interpretation may suggest a conservative approach to cannabis cases. In the case Family of Ryan Wilson v City of Lafayette and Taser International,6 for example, Gorusch ruled that an officer was justified to assume that a person illegally growing cannabis may be armed, thus justifying the fatal use of a taser.

Any increase in uncertainty in an already unclear legislative environment functions as an impediment to cannabis projects in the U.S. Major banks and credit unions remain reluctant to capitalize or facilitate financial transactions for cannabis businesses due to fear of penalization for money laundering. Major U.S. stock exchanges prohibit the listing of cannabis companies, other than one ancillary company, Innovative Industrial Properties, a real estate investment trust that plans to invest in medical cannabis properties. Cannabis companies cannot take advantage of common corporate tax deductions,7 increasing the cost of doing business, and companies must be conservative when developing infrastructure in states with cannabis laws that may be subject to future federal scrutiny. Additionally, trademarks covering cannabis are generally not registrable at the federal level in the U.S., creating a challenge for U.S. companies in the protection of their intellectual property and branding efforts. Unless and until the US Government gives indication that a coherent legalization framework is in its legislative pipeline, growth potential in the U.S. cannabis market is necessarily limited.

Canada's cannabis market is ripe for growth

While the United States cannabis market struggles to determine its future, Canada is rapidly becoming an international leader in the market for cannabis. Canada's federal government is moving quickly to develop a comprehensive cannabis legalization framework. Medical cannabis is already legal at the federal level under the Access to Cannabis for Medical Purposes Regulations ("ACMPR"),8 and although recreational cannabis is still a Schedule II Narcotic under the Controlled Drugs and Substances Act,9 Prime Minister Justin Trudeau's government task force released a road map for the legalization of recreational cannabis by 2018-2019 last December, and the government expects to table legislation this spring. If this legislation is enacted, Canada will be the first G7 nation to fully legalize cannabis, for both medical and recreational purposes.

In addition, Canada's legal cannabis licensing process is structured in a way that has encouraged the development of more sophisticated and better capitalized players than in other areas of the world. Canada currently limits the number of licenses available for producers ("Licensed Producers") under the ACMPR (to date only 38 have been issued),10 and such licenses are tied to specific pieces of production property. As such, companies are incentivized to license a large piece of property and build big, early. Canopy Growth Corp. ("Canopy"), for instance, started with the purchase of a 500,000 square foot chocolate factory for its licensed production site,11 and Aphria Inc. ("Aphria") announced its intention in January 2017 to increase its already large 300,000 square foot capacity under the ACMPR to over 1,000,000 square feet.12

Importantly, better capitalization and favourable market environments have poised Canadian cannabis companies for international expansion. For example, in December 2016, PharmaCan Capital Corp., doing business as Cronos Group ("Cronos"), announced the execution of an exclusive supply agreement with German-based Pedianos GmbH for the distribution of medical cannabis in Europe.13 B.C.-based Tilray has recently become the first North American company to legally export cannabis to the European Union for commercial medical use and has also exported to Australia and Latin America, with approval to begin exporting to New Zealand. Canopy, as well, announced expansion into Australia in May 2016 through a partnership with AusCann Group Holdings.

The recent surge in cannabis-related activity in the Canadian capital markets has also been notable. Medical cannabis companies in Canada alone raised $466 million on Canadian capital markets last year,14 and activity shows no sign of slowing, with over $130 million raised by public Canadian Licensed Producers already in 2017. A recent report commissioned by Deloitte projects the Canadian recreational cannabis retail market to be worth $4.9-$8.7 billion annually, with the potential upside exceeding $20 billion.15

The markets have been similarly active in terms of M&A activity. Canopy, for instance, is the result of a merger between Tweed Inc., Tweed Farms Inc., Bedrocan Canada Inc., and recently Mettrum Health Corp. Combined, Canopy may be the largest legal cannabis company in the world; it received a valuation of over $1 billion in late 2016, and its current market cap is at almost $2 billion. M&A and private equity activity on Canadian markets has not been limited to Canadian interests. Companies such as International Cannabis Corp. and CannaRoyalty Corp. have accessed the Canadian capital markets or listed themselves on Canada's stock exchanges.

In summary, Canada's more favourable regulatory environment has fostered better access to capital, more confident M&A activity and more rapid company growth in its legal cannabis market than its southern neighbours. Its market, as such, has been able to mature faster than the U.S., and, given the likelihood of a comprehensive legalization framework in the next year, this progress shows no signs of slowing. While the United States is unlikely to backpedal in its own recent progress toward cannabis legalization, the speed of its market growth in a rapidly developing industry is currently limited by its uncertain political and legal climate at the federal level. Canada, as such, has an opportunity to leverage its already larger and more sophisticated players to attract top talent, establish presence as a research and development leader and grow its international industry presence to become a global leader in the market for legalized cannabis.

This article was written with the helpful contribution of Michael Garbuz (Articling Student).


1. Controlled Substances Act of 1970. Pub L No. 91-513, 84 Stat 1242.

2. Cole , James, "Memorandum from the U.S. Department of Justice, Office of the Deputy Attorney General to all United States Attorneys, Subject: Guidance Regarding Marijuana Enforcement" Office of Public Affairs, online: August 29, 2013 (

3. Washington, Colorado, Alaska, Oregon, California, Massachusetts, Nevada and Maine.

4. John Kajia & Sam Osborn, eds, "The State of Legal Legal Marijuana Markets Executive Summary: 4th Edition", ArcView Market Research and New Frontier Data, online: 2016 (

5. Abigail Geiger, "Support for marijuana legalization continues to rise", (

6. 10th Cir. R. 32.1, online: (

7. Section 280E of the IRS code prohibits businesses from deducting expenses from trafficking of a controlled substance, which in turn precludes cannabis businesses from deducting for cost of goods sold.

8. SOR/2016-230.

9. SC 1996, c 19.

10. "Authorized Licensed Producers for Medical Purposes", Health Canada, online: Feb 7, 2017 (

11. "Welcome to Canopy Growth", Canopy Growth Corporation, online: (

12. "Aphria's Vision to be Reality – Part IV expansion project to increase greenhouse growing space to 1 million square feet" Aphria, online: January 17, 2017 (

13 . "Canada's Cronos Group Signs Deal to Supply Medical Cannabis in Europe" PharmaCan Capital Corp online: December 29 2016 (

14. Sunny Freeman, "Why smaller banks take bigger slice of the growing medical marijuana business", Financial Post, online: January 30 2017, (

15. "Recreational Marijuana: Insights and Opportunities" Deloitte, online: 2016 (

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions